Provided are formulations of a stable commercial paroxetine tablet comprising paroxetine hydrochloride anhydrous, povidone, copovidone or HPMC as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method.

 
Web www.patentalert.com

< Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

> Compositions and methods for modifying toxic effects of proteinaceous compounds
~ 00446